Glimepiride Cristers (Glimepiride)

Glimepiride Cristers is indicated for the management of type 2 diabetes mellitus when diet, exercise, and other oral agents are insufficient to achieve glycemic targets.

• Used as monotherapy in patients who cannot tolerate metformin.
• Added to existing metformin therapy to enhance glucose control.
• May be combined with other oral antihyperglycemic agents such as DPP‑4 inhibitors.
• Intended for adults with adequate pancreatic beta‑cell function.
• Helps reduce fasting and post‑prandial blood glucose levels.

Glimepiride Cristers may cause a range of side effects, some of which are common and others that require immediate medical attention.

Common

• Mild hypoglycemia, especially when meals are skipped.
• Nausea or abdominal discomfort.
• Headache or dizziness.
• Weight gain.
• Skin rash or pruritus.

Serious

• Severe hypoglycemia with confusion, seizures, or loss of consciousness.
• Allergic reactions such as angioedema or Stevens‑Johnson syndrome.
• Hepatotoxicity indicated by jaundice or elevated liver enzymes.
• Hematologic abnormalities like leukopenia or thrombocytopenia.

Before starting Glimepiride Cristers, certain precautions should be considered to minimize risks.

• Assess renal and hepatic function; dose adjustment may be needed in impairment.
• Use cautiously in elderly patients due to increased hypoglycemia risk.
• Avoid in patients with known sulfonylurea hypersensitivity.
• Monitor blood glucose regularly, especially during dose changes.
• Counsel patients on recognizing and managing hypoglycemia.
• Discontinue during pregnancy or breastfeeding unless clearly indicated.

Glimepiride Cristers can interact with several drug classes, influencing its efficacy or safety profile.

Avoid

• Concurrent use with other sulfonylureas or insulin, which may precipitate severe hypoglycemia.
• Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) that increase glimepiride plasma levels.
• MAO‑B inhibitors, which can potentiate hypoglycemic effects.

Use with caution

• Beta‑blockers, as they may mask hypoglycemia symptoms.
• Thiazide diuretics, which can raise blood glucose.
• Corticosteroids or oral contraceptives that may reduce glimepiride effectiveness.
• Alcohol, which can potentiate hypoglycemia, especially on an empty stomach.